201 related articles for article (PubMed ID: 23499892)
1. Minnelide reduces tumor burden in preclinical models of osteosarcoma.
Banerjee S; Thayanithy V; Sangwan V; Mackenzie TN; Saluja AK; Subramanian S
Cancer Lett; 2013 Jul; 335(2):412-20. PubMed ID: 23499892
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Sp1 by Minnelide leads to decrease in HSP70 and decrease in tumor burden of gastric cancer.
Arora N; Alsaied O; Dauer P; Majumder K; Modi S; Giri B; Dudeja V; Banerjee S; Von Hoff D; Saluja A
PLoS One; 2017; 12(2):e0171827. PubMed ID: 28192510
[TBL] [Abstract][Full Text] [Related]
3. Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F.
Oliveira A; Beyer G; Chugh R; Skube SJ; Majumder K; Banerjee S; Sangwan V; Li L; Dawra R; Subramanian S; Saluja A; Dudeja V
Lab Invest; 2015 Jun; 95(6):648-659. PubMed ID: 25893635
[TBL] [Abstract][Full Text] [Related]
4. A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.
Chugh R; Sangwan V; Patil SP; Dudeja V; Dawra RK; Banerjee S; Schumacher RJ; Blazar BR; Georg GI; Vickers SM; Saluja AK
Sci Transl Med; 2012 Oct; 4(156):156ra139. PubMed ID: 23076356
[TBL] [Abstract][Full Text] [Related]
5. Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo.
Rousalova I; Banerjee S; Sangwan V; Evenson K; McCauley JA; Kratzke R; Vickers SM; Saluja A; D'Cunha J
PLoS One; 2013; 8(10):e77411. PubMed ID: 24143232
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.
Giri B; Gupta VK; Yaffe B; Modi S; Roy P; Sethi V; Lavania SP; Vickers SM; Dudeja V; Banerjee S; Watts J; Saluja A
J Transl Med; 2019 May; 17(1):163. PubMed ID: 31109340
[TBL] [Abstract][Full Text] [Related]
7. Triptolide enhances the tumoricidal activity of TRAIL against renal cell carcinoma.
Brincks EL; Kucaba TA; James BR; Murphy KA; Schwertfeger KL; Sangwan V; Banerjee S; Saluja AK; Griffith TS
FEBS J; 2015 Dec; 282(24):4747-4765. PubMed ID: 26426449
[TBL] [Abstract][Full Text] [Related]
8. AMD3100 combined with triptolide inhibit proliferation, invasion and metastasis and induce apoptosis of human U2OS osteosarcoma cells.
Jiang C; Fang X; Zhang H; Wang X; Li M; Jiang W; Tian F; Zhu L; Bian Z
Biomed Pharmacother; 2017 Feb; 86():677-685. PubMed ID: 28038429
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug.
Rivard C; Geller M; Schnettler E; Saluja M; Vogel RI; Saluja A; Ramakrishnan S
Gynecol Oncol; 2014 Nov; 135(2):318-24. PubMed ID: 25172764
[TBL] [Abstract][Full Text] [Related]
10. Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer.
Modi S; Kir D; Giri B; Majumder K; Arora N; Dudeja V; Banerjee S; Saluja AK
J Gastrointest Surg; 2016 Jan; 20(1):13-23; discussion 23-4. PubMed ID: 26503259
[TBL] [Abstract][Full Text] [Related]
11. Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
Banerjee S; Sangwan V; McGinn O; Chugh R; Dudeja V; Vickers SM; Saluja AK
J Biol Chem; 2013 Nov; 288(47):33927-33938. PubMed ID: 24129563
[TBL] [Abstract][Full Text] [Related]
12. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants.
Isharwal S; Modi S; Arora N; Uhlrich C; Giri B; Barlass U; Soubra A; Chugh R; Dehm SM; Dudeja V; Saluja A; Banerjee S; Konety B
Prostate; 2017 May; 77(6):584-596. PubMed ID: 28144973
[TBL] [Abstract][Full Text] [Related]
13. Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma.
Caicedo-Granados E; Lin R; Fujisawa C; Yueh B; Sangwan V; Saluja A
Oral Oncol; 2014 Dec; 50(12):1149-56. PubMed ID: 25311433
[TBL] [Abstract][Full Text] [Related]
14. Triptolide-mediated cell death in neuroblastoma occurs by both apoptosis and autophagy pathways and results in inhibition of nuclear factor-kappa B activity.
Krosch TC; Sangwan V; Banerjee S; Mujumdar N; Dudeja V; Saluja AK; Vickers SM
Am J Surg; 2013 Apr; 205(4):387-96. PubMed ID: 23428154
[TBL] [Abstract][Full Text] [Related]
15. Triptolide inhibits proliferation and induces apoptosis of human melanoma A375 cells.
Tao Y; Zhang ML; Ma PC; Sun JF; Zhou WQ; Cao YP; Li LJ
Asian Pac J Cancer Prev; 2012; 13(4):1611-5. PubMed ID: 22799376
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib and triptolide as combination therapy for hepatocellular carcinoma.
Alsaied OA; Sangwan V; Banerjee S; Krosch TC; Chugh R; Saluja A; Vickers SM; Jensen EH
Surgery; 2014 Aug; 156(2):270-9. PubMed ID: 24953273
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt/β-Catenin signaling.
Li X; Lu Q; Xie W; Wang Y; Wang G
Biochem Biophys Res Commun; 2018 Feb; 496(2):443-449. PubMed ID: 29330051
[TBL] [Abstract][Full Text] [Related]
18. Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.
Kumar A; Corey C; Scott I; Shiva S; D'Cunha J
PLoS One; 2016; 11(8):e0160783. PubMed ID: 27501149
[TBL] [Abstract][Full Text] [Related]
19. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
[TBL] [Abstract][Full Text] [Related]
20. Triptolide induces the cell apoptosis of osteosarcoma cells through the TRAIL pathway.
Zhao X; Zhang Q; Chen L
Oncol Rep; 2016 Sep; 36(3):1499-505. PubMed ID: 27461934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
